Zimmer Partners’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$329K Sell
6,960
-17,540
-72% -$828K 0.01% 133
2025
Q1
$957K Buy
+24,500
New +$957K 0.02% 138